CIK 0001468929
- Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264042544
- Phone
- +1 215-702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at $1.59 ($7,950)
- 4 Open-market buy Director bought 7,500 shares at $1.44 ($10,825)
- 4/A Open-market buy Director bought 7,100 shares at an average $1.18 ($8,367)
- 4 Open-market buy Director bought 7,100 shares at an average $1.39 ($9,868)
- 4 Open-market buy Director bought 5,000 shares at $1.66 ($8,280)
- 4 Open-market buy Director bought 1,648 shares at $1.68 ($2,769)
- 4 Open-market buy Director bought 5,000 shares at $1.73 ($8,650)
- 4 Open-market buy Director bought 5,372 shares at an average $1.85 ($9,946)
- 4 Open-market buy Director bought 3,128 shares at $1.60 ($4,993)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at an average $1.61 ($32,172)
- 4 Open-market buy Director bought 5,000 shares at $1.90 ($9,500)
- 4 Open-market buy CEO bought 1,250 shares at $1.89 ($2,360)
- 4 Open-market buy Director bought 5,300 shares at $1.89 ($10,010)
- 4 Open-market buy Director bought 5,500 shares at $1.87 ($10,285)
- 4 Open-market buy Director bought 9,091 shares at $5.49 ($49,910)
- 4 Open-market buy Director bought 1,819 shares at $5.49 ($9,986)
- 4 Open-market buy Director bought 28,000 shares at $5.49 ($153,720)
- 4 Open-market buy Director bought 9,091 shares at $5.49 ($49,910)
- 4 Open-market buy Director bought 5,000 shares at $5.49 ($27,450)
Page 5 of 6 · 115 filings